Measure Title: RELATING TO HEALTH CARE COSTS.
Report Title: DOH; Insurance Commissioner; Health Care; Costs; Prescription Drug Affordability Board; Upper Payment Limits; Out-of-Pocket Maximums; Copayment Adjustment Programs; Reports; Rules; Appropriation ($)
Description: Establishes the Prescription Drug Affordability Board within the Department of Health to conduct affordability reviews on high-cost prescription drugs and establish upper payment limits under certain circumstances. Establishes out-of-pocket maximums for prescribed insulin, asthma inhalers, and epinephrine auto-injectors. Prohibits copayment adjustment programs. Requires health insurers, mutual benefit societies, and health maintenance organizations to comply with certain affordability measures. Requires annual reports to the Legislature. Requires adoption of rules by the Affordability Board and Insurance Commissioner. Appropriates funds.
Companion:
Package: None
Current Referral: HHS/CPN, WAM/JDC
Introducer(s): MCKELVEY, CHANG, HASHIMOTO, KIDANI
Act:

Sort by DateChamberStatus Text
2/13/2026SThe committee(s) on HHS/CPN has scheduled a public hearing on 02-17-26 9:45AM; Conference Room 229 & Videoconference.
1/30/2026SReferred to HHS/CPN, WAM/JDC.
1/26/2026SPassed First Reading.
1/23/2026SIntroduced.

S = Senate | H = House | D = Data Systems | $ = Appropriation measure | ConAm = Constitutional Amendment

Some of the above items require Adobe Acrobat Reader. Please visit Adobe's download page for detailed instructions.


SB2933

All Versions of this Measure

Committee Reports

No other committee reports available at this time. You may search in our Document Directories if you believe this message is in error. The link is on the home page under Search.

Testimony

No testimony available at this time.

Hearing Notices

HHS/CPN
2/17/26 9:45A
CR 229 & Videoconference